We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Mallinckrodt Plc () | USOTC:MNKKQ | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.02 | 0.00 | 01:00:00 |
From May 2021 to May 2024
The Justice Department alleged that Mallinckrodt ARD LLC, started calculating and paying rebates as if Acthar was a new drug first marketed in 2013 after the Food and Drug Administration approved a new indication for its use in 2010. "U.S. Sues Mallinckrodt for Allegedly Underpaying Medicaid Rebates," on March 3, 2020, incorrectly referred to the agency as the federal drug administration.
(END) Dow Jones Newswires
June 14, 2021 14:26 ET (18:26 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Mallinckrodt () Chart |
1 Month Mallinckrodt () Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
